Sui holds the 2nd Summit Forum of the Eye Health Industry in the Guangdong -Hong Kong -Macao Greater Bay Area

On August 27th, the 2022 Lingnan Science Forum Series -the 2nd Summit Forum and the New Progress of Eye Diagnosis and Treatment of Eye Health Industry in the Guangdong -Hong Kong -Macao Greater Bay Area was held on the 8th floor of the International Hotel in Asia, Guangdong.

meeting venue

This forum brings together experts in the domestic eye health industry and optical instruments, biomedicine, traditional Chinese medicine, photoelectric lighting and other industries. Ophthalmologists and professors from Guangdong, Hong Kong, Macao, and Hong Kong, Hong Kong, Macao have carried out innovation Sexual, cross -industry, and cross -sectarian exchanges and cooperation, guide the diversification, characteristic, and professional development of the eye health industry to innovate and entrepreneurship.

In part of the theme report, the Three Eye Ophthalmology experts and professors have made the "Progress and Challenge of Retic Organic Transplantation and Challenges", "Children and Adolescent Patriotic Conditions and Prevention Measures", "Wide -angle contact mirror PDR vitreous retinal surgery skills", "Chinese medicine treatment" Matsyus lesion ideas and case sharing "" Following Life Related Dry Eyes "," Glory Return-Non-Remitted Arts inheritance "," AI Eye Eye Viewing the whole body-intelligent chemical diagnosis and treatment system of eye and cardiopathy " Seventeen academic reports such as the New Progress of diagnosis and treatment "and" New Age of Corneal Transplantation -ingredients Corner Transplantation ".

Ge Jian, from the National Key Laboratory of Zhongshan Ophthalmology Center and the National Key Laboratory of Ophthalmology, pointed out in the report of the "Retinal Organ Transplantation and Challenges" that people are familiar with visual blindness before neurological blindness such as glaucoma and elderly macular lesions. However, the research on retinal organ transplantation has already achieved the latest research progress and achieved effective results. High -efficiency, convenient, and optimizing large -scale seeds to obtain clinical levels, transplant micro -environment and immune regulation, research and development of compatible bracket materials, accurate and simple and minimally invasive surgical equipment and surgical processes. Functional reconstruction.

Professor Yu Honghua from the Ophthalmology Center of the People's Hospital of Guangdong Province introduced in detail "AI Viewing Eye Gangs-Intelligent Chemical Diagnosis and Treatment System of Eye and Cardiac, Encephalopenic and Nephrine. Analysis of the relevant situation of technological innovation and research and development, and for the first time, it proposed a new type of aging logo-the age of retina.

Professor Liu Xin from the Department of Clinical Department of the School of Traditional Chinese Medicine of Hong Kong Baptist University shared with you the "Concept and Case Sharing of TCM Treatment of Matsyal Lesson Certificate and Cases". Traditional Chinese medicine ophthalmology has a long history, and has been formally established in the Song Dynasty for more than 1,300 years. Scope of treatment: Almost all eye diseases are covered, and the treatment methods include internal treatment-drug treatment, external treatment-surgery, acupuncture, smoke, local dot medicine, etc. Traditional Chinese Medicine Ophthalmology is the main treatment of ophthalmological diseases. Modern Chinese Medicine Ophthalmology Certificate of Ophthalmology presents the characteristics of the new era: "combination of disease syndrome". This is the basic direction of the current development of Chinese medicine ophthalmology and an important clinical research model for modern Chinese medicine ophthalmology.

According to research reports provided by experts, with the rapid development of my country's economy and society and aging population, people’s diet structure, eye environment, and eye habits have undergone tremendous changes. For example: age -related eye disease, hypertensive eye disease, diabetic eye disease, glaucoma and other diseases have increased year by year, and problems such as myopia in children and adolescents are becoming increasingly prominent. As of now, my country is still one of the countries with the largest number of patients in the world and the largest number of patients in the world, and has risen year by year. The number of cataract patients in my country rose from 109.76 million in 2015 to 126.45 million in 2019, and the number of white internal barricades in 2020 was as high as 130.72 million. The number of patients in my country has also increased year by year. In 2020, adult myopia increased to 316.91 million, and adult remote vision increased to 229.77 million.

The rise in the number of patients is driving the increase in the demand for health. From the entire industrial chain, China's eye health markets can be subdivided into medical devices (16%), ophthalmological drugs (11%), and ophthalmology services (73%). At present, the domestic ophthalmological upstream markets are mainly occupied by imported products, but in recent years, domestic manufacturers have achieved breakthroughs in the fields of artificial lens, corneal contact mirrors. In the future, domestic brands have imported alternative space. In the field of ophthalmology equipment and consumables, there is a huge gap between domestic brands and imported products in terms of technology and quality, but it has strong cost advantages. At the same time The popularity of expensive ophthalmology equipment and consumables.

This forum is directed by the Guangdong Provincial Science and Technology Association and the Guangdong Provincial Department of Science and Technology, hosted by the Guangdong Eye Health Association, and organized by the Guangdong Science and Technology Journalist Association. ((

- END -